Delivery Order SPE2DB22D2211-SPE2DB25FSFWK
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,724.87 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 9, 2025, with completion scheduled for September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a pharmaceutical supply delivery under DLA's medical procurement operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,800.96 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 29, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $14,843.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens. The award, which carries an ultimate completion date of September 24, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.98 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 12.5 mg/0.5 mL pen injections on August 29, 2025, with completion scheduled for September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 15, 2025. This firm fixed-price, non-set-aside delivery order, which is due for completion by September 16, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pen injections totaling $1,539.10 on September 3, 2025, with completion scheduled for September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procurement procedures. The pharmaceutical will be delivered to the company's facility in Conshohocken, Pennsylvania, serving as the place of performance....
- The Defense Logistics Agency awarded a delivery order valued at $12,759.36 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,645.08 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a single delivery order for the diabetes medication to support federal healthcare needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro (tirzepatide) 10 mg/0.5 mL pens valued at $1,088.36. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside provisions, indicating it was competitively awarded. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,187.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with a completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken,...